GeneDx Holdings (WGS)

• Market cap: $2.37B
• 1 day: -4.54%
• 5 days: -15.59%
• 1 month: -10.39%
• 3 months: 6.18%
• 6 months: 96.45%
• Year to date: 6.18%
• 1 year: 836.32%
• 5 years: -73.86%
• 10 years: -73.86%
• Sector: Healthcare
• Industry: Health Services

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

344% more first-time investments, than exits

New positions opened: 80 | Existing positions closed: 18

125% more capital invested

Capital invested by funds: $802M [Q3] → $1.81B (+$1B) [Q4]

109% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 33

94% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $9.6M

67% more funds holding in top 10

Funds holding in top 10: 6 [Q3] → 10 (+4) [Q4]

44% more funds holding

Funds holding: 136 [Q3] → 196 (+60) [Q4]

15.4% more ownership

Funds ownership: 70.11% [Q3] → 85.51% (+15.4%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $80 5% downside
• Avg. target: $99 17% upside
• High target: $118 40% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Goldman Sachs Matthew Sykes 43% 1-year accuracy 16 / 37 met price target	5% downside $80	Neutral Maintained	19 Feb 2025
TD Cowen Dan Brennan 29% 1-year accuracy 8 / 28 met price target	40% upside $118	Buy Maintained	7 Jan 2025